CEG-0598, a novel dual inhibitor of EGFR and C5aR demonstrates in vitro anticancer and antimetastatic activity in prostate cancer cells DOI Creative Commons
Ayed A. Dera,

Majed Al Fayi

Discover Oncology, Journal Year: 2025, Volume and Issue: 16(1)

Published: May 9, 2025

Language: Английский

CEG-0598, a novel dual inhibitor of EGFR and C5aR demonstrates in vitro anticancer and antimetastatic activity in prostate cancer cells DOI Creative Commons
Ayed A. Dera,

Majed Al Fayi

Discover Oncology, Journal Year: 2025, Volume and Issue: 16(1)

Published: May 9, 2025

Language: Английский

Citations

0